In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Orudis, Oruvail, Ketoflam, Orudis KT, Ketoprofen Drug Master File in Korea (Orudis, Oruvail, Ketoflam, Orudis KT, Ketoprofen KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Orudis, Oruvail, Ketoflam, Orudis KT, Ketoprofen. The MFDS reviews the Orudis, Oruvail, Ketoflam, Orudis KT, Ketoprofen KDMF as part of the drug registration process and uses the information provided in the Orudis, Oruvail, Ketoflam, Orudis KT, Ketoprofen KDMF to evaluate the safety and efficacy of the drug.
After submitting a Orudis, Oruvail, Ketoflam, Orudis KT, Ketoprofen KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Orudis, Oruvail, Ketoflam, Orudis KT, Ketoprofen API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Orudis, Oruvail, Ketoflam, Orudis KT, Ketoprofen suppliers with KDMF on PharmaCompass.